24 January 2024

A recent wave of increased hospitalizations for respiratory infections in Northern China is the result of Mycoplasma pneumoniae, a bacterial infection that is usually mild and affects children and young adults causing respiratory symptoms or, in some cases, mild pneumonia.

But this shouldn’t come as a surprise. Not just because a surge of respiratory infections had been anticipated in China following the relaxing of strict COVID-19-related restrictions but also because previous levels of drug resistance to M. pneumonia, as high as 90%, have been reported in Beijing.

Read the article